Skip to main content

Eprosartan Side Effects

Medically reviewed by Last updated on Jun 28, 2024.

Applies to eprosartan: oral tablet.


Oral route (Tablet)

Drugs that act on the renin-angiotensin system can cause injury or death to the developing fetus when used during the second and third trimesters. When pregnancy is confirmed, discontinue treatment immediately.

Serious side effects of Eprosartan

Along with its needed effects, eprosartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking eprosartan:

Less common


Other side effects of Eprosartan

Some side effects of eprosartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare

For Healthcare Professionals

Applies to eprosartan: oral tablet.


The most common adverse reactions were headache and unspecific gastrointestinal complaints.[Ref]

Nervous system

Very common (10% or more): Headache (up to 11%)

Common (1% to 10%): Dizziness

Frequency not reported: Ataxia, migraine, neuritis, paresthesia, somnolence, tremor, vertigo, tinnitus[Ref]


Common (1% to 10%): Unspecific gastrointestinal complaints, abdominal pain, diarrhea, dyspepsia

Frequency not reported: Constipation, dry mouth, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, nausea, periodontitis, toothache, vomiting[Ref]


Common (1% to 10%): Rhinitis, upper respiratory tract infection, pharyngitis, coughing, sinusitis, dyspnea, bronchitis

Frequency not reported: Asthma, epistaxis[Ref]


Common (1% to 10%): Asthenia, injury, chest pain, fatigue, pain

Uncommon (0.1% to 1%): Facial edema

Frequency not reported: Substernal chest pain, peripheral edema, fever, influenza-like symptoms, malaise[Ref]


Common (1% to 10%): Myalgia, arthralgia, back pain

Frequency not reported: Rigors, creatine phosphokinase increased, arthritis, arthritis aggravated, arthrosis, skeletal pain, tendinitis, leg cramps[Ref]


Common (1% to 10%): Palpitation, dependent edema

Uncommon (0.1% to 1%): Hypotension

Frequency not reported: Hot flushes, angina pectoris, bradycardia, ECG abnormal, ECG specific abnormal, extrasystoles, atrial fibrillation, tachycardia, peripheral ischemia[Ref]


Common (1% to 10%): Neutrophils 1500/mm3 or less

Uncommon (0.1% to 1%): Hemoglobin decreased greater than 20%, WBC count of 3000/mm3 or less, platelets 100 x 10(9)/L or less

Frequency not reported: Anemia, leukopenia[Ref]


Common (1% to 10%): Hypertriglyceridemia

Uncommon (0.1% to 1%): Potassium 5.6 mmol/L or greater

Frequency not reported: Alcohol intolerance, anorexia, diabetes mellitus, gout, hypercholesterolemia, hyperglycemia, hyperkalemia, hypokalemia, hyponatremia[Ref]


Common (1% to 10%): Allergic skin reactions

Uncommon (0.1% to 1%): Angioedema

Frequency not reported: Purpura, eczema, furunculosis, pruritus, rash, maculopapular rash, sweating increased[Ref]


Common (1% to 10%): Viral infection

Uncommon (0.1% to 1%): Hypersensitivity

Frequency not reported: Herpes simplex, otitis externa, otitis media[Ref]


Common (1% to 10%): BUN increased

Uncommon (0.1% to 1%): Creatinine increased

Frequency not reported: Renal calculus

Postmarketing reports: Impaired renal function, renal failure[Ref]


Common (1% to 10%): Urinary tract infection

Frequency not reported: Glycosuria, albuminuria, cystitis, hematuria, micturition frequency, polyuria, urinary incontinence[Ref]


Common (1% to 10%): Depression

Frequency not reported: Anxiety, insomnia, nervousness[Ref]


Uncommon (0.1% to 1%): ALT greater than 3.5 times the upper limit of normal

Frequency not reported: Serum glutamic oxaloacetic transaminase (SGOT) increased, serum glutamic pyruvic transaminase (SGPT) increased, ALT increased, AST increased, alkaline phosphatase increased[Ref]


Frequency not reported: Conjunctivitis, vision abnormal, xerophthalmia[Ref]


1. (2001) "Product Information. Teveten (eprosartan)." SmithKline Beecham

2. Cerner Multum, Inc. "UK Summary of Product Characteristics."

3. Cerner Multum, Inc. "Australian Product Information."

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.